Evidence that “on-demand” PrEP taken before and after sex can prevent HIV

How many doses of Truvada-based PrEP (pre-exposure prophylaxis) are needed to provide adequate protection against HIV? Might it be possible to take PrEP only before and after sex—instead of every day?

A recent article published in The Lancet HIV provides insight into this very question.

  • Read more here
  • Access Lancet HIV abstract here (for full text please see your librarian)

Women under-represented in HIV clinical trials

nam/aidsmap, 08 February 2016

Less than a quarter of people taking part in clinical trials for antiretroviral medications are women, potentially limiting the generalisability of findings, according to a systematic review published in the February 1 edition of the Journal of Acquired Immune Deficiency Syndromes.

Read more here